Drug intelligence / Profile preview

A-769662

Development stage
Preclinical
Lead developer
Abbott
Modality
Small Molecules
Administration
In Vitro, Preclinical (animal Studies, Typically Injection Or Oral Gavage)
01

Overview

A-769662 is a **potent, reversible, direct activator of AMP-activated protein kinase (AMPK)**, specifically binding to heterotrimers containing the β1 regulatory subunit. Unlike indirect AMPK activators such as metformin and AICAR, A-769662 binds at a site distinct from AMP, allosterically activating AMPK and inhibiting its dephosphorylation. It acts via the carbohydrate-binding module of the β subunit and the kinase domain interface, promoting phosphorylation of downstream AMPK targets, notably acetyl-CoA carboxylase (ACC). This leads to metabolic effects such as inhibition of fatty acid synthesis and anti-inflammatory effects in rodent models of endotoxemia and inflammatory arthritis[1][3][4][5][6][7]. Developed as a **synthetic research tool**, it has demonstrated efficacy in vitro and in preclinical animal models but is not intended for therapeutic or diagnostic human use.

Other names
A 769662A769662A-769662thienopyridone derivative
02

Targets

26S proteasomePRKAB1 (AMPK β1)

Beyond the preview

Go deeper on A-769662.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-769662.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call